
NSCLC accounts for about 85% of lung cancers and includes predominantly adenocarcinomas and squamous cell carcinomas. In the United States, about 15% of patients with NSCLC have mutations in Epidermal Growth Factor Recepter (EGFR). Testing for EGFR...
Read More ›
Colorectal cancer (CRC) remains the third leading cause of cancer-related deaths in the United States and nearly 50% of patients will experience metastases during their lives. Anti EGFR targeted therapy is used for treatment of metastatic colorectal...
Read More ›
Test code: L186 The spectrum of abnormalities in serum immunoglobulin concentrations is broad. Abnormal concentrations range from a virtual absence of one or more of the three major classes of immunoglobulin (IgG, IgA and IgM) to polyclonal...
Read More ›
Test code: L188 The spectrum of abnormalities in serum immunoglobulin concentrations is broad. Abnormal concentrations range from a virtual absence of one or more of the three major classes of immunoglobulin (IgA, IgG and IgM) to polyclonal...
Read More ›
Test code: L187 The spectrum of abnormalities in serum immunoglobulin concentrations is broad. Abnormal concentrations range from a virtual absence of one or more of the three major classes of immunoglobulin (IgA, IgG and IgM) to polyclonal...
Read More ›
Test code: L645 Methodology: Immunoturbidimetric Specimen Required: Patient Prep: Fasting specimen preferred. Collect: Serum Separator Tube (SST) – 0.5 ml. Specimen Preparation: Allow specimen to clot completely at room temperature . Separate...
Read More ›